[S-21] Symposium 21「Physician-Initiated Clinical Trials for Drug Repositioning: Experiences and Future Challenges」

Thu. May 30, 2024 3:30 PM - 5:30 PM Room5 (Hall B5 (2), B Block, 5F, TIF)

Chair(s): Masayuki Nakamori (Department of Neurology, Yamaguchi University, Japan), Sonoko Misawa (Department of Neurology, Chiba University Graduate School of Medicine, Japan)

+Add all to schedule

[S-21-1] An investigator-initiated clinical trial of taurine for MELAS

Yoshihide Sunada (President, Kawasaki Medical School, Japan)

[S-21-2] Investigator-initiated clinical trial of bosutinib for amyotrophic lateral sclerosis

Keiko Imamura¹, Yuishin Izumi², Haruhisa Inoue¹ (1.Center for iPS Cell Research and Application, Kyoto University, Japan, 2.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan)

[S-21-3] Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis

Shin Kwak, Hitoshi Aizawa (Tokyo Medical University, Japan)

[S-21-4] Efficacy and Safety of Ultrahigh Dose Mecobalamin in Early-Stage ALS: A Randomized Clinical Trial

Ryosuke Oki¹, Yuishin Izumi², Satoshi Kuwabara³, Ryuji Kaji⁴, JETALS collaborators⁵ (1.Department of Neurology, Tokushima University Hospital, Japan, 2.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 3.Department of Neurology, Chiba University Graduate School of Medicine, Japan, 4.Tokushima University, Japan, 5.JETALS, Japan)